English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 19 May 2023, 07:00 HKT/SGT

Source: CellOxess Biotechnology
Fertilix Proven Effective in Blocking Damage From Low-Dose Exposure to Chemicals Commonly Found in Plastic Consumer Products

CLERMONT-FERRAND, FRANCE, May 19, 2023 - (ACN Newswire) - According to a recent study by Universite Clermont Auvergne researchers, exposure to chemical additives and building blocks commonly used in everyday plastic products, even in low doses, can cause significant damage to the genetic material carried by sperm cells.

Fertilix(R) logo

The study, led by Professor Joel Drevet, examined two common chemicals widely used in the plastic industry: dibutyl phthalate and bisphenol AF. These chemicals have long been linked to lowering male fertility, but the novelty of this study was in evaluating doses that were previously considered safe or inconsequential for consumers. While researchers found no appreciable effect on general semen parameters typically examined in fertility clinics such as sperm counts and motility, significant oxidation and decompaction of DNA structure in sperm cells were observed. This is concerning because damage to paternal genetic material can expose the female partner to higher risk of pregnancy loss and potentially impact the health of the offspring. Interestingly, the study also showed that co-administration with micronutrient supplement Fertilix(R) significantly blocked the damaging effects of these chemicals on sperm DNA.

Given that microplastics are found everywhere in our surroundings, these findings underscore the importance of greater public awareness and the urgency for the plastic industry to replace such substances with biodegradable or natural alternatives. Furthermore, fertility experts counseling couples ahead of natural or assisted conception should advocate for preconceptual supplementation and possible lifestyle modifications that may mitigate the impact of environmental pollutants.

This study is now available with open-access in Antioxidants, a premier journal in antioxidant research, and can be downloaded here. https://www.mdpi.com/2076-3921/12/5/1046 CellOxess Biotechnology, the designer and manufacturer of Fertilix(R) formulations, will present the full results of this study at the European Society of Human Reproduction and Embryology (ESHRE) annual meeting this June in Copenhagen, Denmark.

Contact Information
Frances Gallagher, MPH
Marketing & Communications Coordinator

Topic: Press release summary
Source: CellOxess Biotechnology

Sectors: BioTech, Healthcare & Pharm
From the Asia Corporate News Network

Copyright © 2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Latest Press Releases
New Safety Research Sheds Light on Crucial Child Safety Product Concerns  
Sept 28, 2023 21:30 HKT/SGT
Appia Provides Update on its Extensive Drilling Program at its PCH Ionic Clay Project, Brazil  
Sept 28, 2023 20:59 HKT/SGT
Palladium One Announces Multiple Drill Ready Targets on the Tyko II Nickel - Copper Project, Ontario, Canada  
Sept 28, 2023 18:39 HKT/SGT
Israeli Technology Company BYND Cannasoft Launches EZ-G Device for Women's Health Website  
Sept 28, 2023 18:00 HKT/SGT
Eisai Launches New "Innovation" Page on Corporate Website  
Thursday, September 28, 2023 4:05:00 PM
Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance"  
Thursday, September 28, 2023 1:49:00 PM
AEON Credit Revenue Up 37.0% to HK$783.1 Million in 1H2023, Profit Increases 8.3% to HK$191.4 Million  
Sept 28, 2023 13:41 HKT/SGT
NEC sets record for 800 Gbps long-distance transmission over an optical submarine cable system  
Thursday, September 28, 2023 12:56:00 PM
Fourth Paradigm, a Leader in Enterprise AI, Listed on the Main Board of the Hong Kong Stock Exchange  
Sept 28, 2023 12:53 HKT/SGT
JCB launches a special offer program in Hokkaido for inbound tourist to Japan  
Thursday, September 28, 2023 12:00:00 PM
More Press release >>
More events >>
Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575